Impacts of ischemic preconditioning in liver resection: systematic review with meta-analysis

To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. Liver surgeries are usually associated with intentional transient ischemia for hemostatic control. IPC is a surgical step that intends to reduce the effects of i...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of surgery (London, England) Vol. 109; no. 6; pp. 1720 - 1727
Main Authors de Oliveira, Glauber C, de Oliveira, Walmar K, Yoshida, Winston B, Sobreira, Marcone L
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 01.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. Liver surgeries are usually associated with intentional transient ischemia for hemostatic control. IPC is a surgical step that intends to reduce the effects of ischemia-reperfusion; however, there is no strong evidence about the real impact of the IPC, and it is necessary to effectively clarify what its effects are. Randomized clinical trials were selected, comparing IPC with no preconditioning in patients undergoing liver resection. Data were extracted by three independent researchers according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, Supplemental Digital Content 1, http://links.lww.com/JS9/A79 . Several outcomes were evaluated, including postoperative peaks of transaminases and bilirubin, mortality, length of hospital stay, length of stay in the ICU, bleeding, and transfusion of blood products, among others. Bias risks were assessed using the Cochrane collaboration tool. Seventeen articles were selected, with a total of 1052 patients. IPC did not change the surgical time of the liver resections while these patients bled less (Mean Difference: -49.97 ml; 95% CI: -86.32 to -13.6; I2 : 64%), needed less blood products [relative risk (RR): 0.71; 95% CI: 0.53-0.96; I2 =0%], and had a lower risk of postoperative ascites (RR: 0.40; 95% CI: 0.17-0.93; I2 =0%). The other outcomes had no statistical differences or could not have their meta-analyses conducted due to high heterogeneity. IPC is applicable in clinical practice, and it has some beneficial effects. However, there is not enough evidence to encourage its routine use.
AbstractList Objective: To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. Summary Background Data: Liver surgeries are usually associated with intentional transient ischemia for hemostatic control. IPC is a surgical step that intends to reduce the effects of ischemia–reperfusion; however, there is no strong evidence about the real impact of the IPC, and it is necessary to effectively clarify what its effects are. Methods: Randomized clinical trials were selected, comparing IPC with no preconditioning in patients undergoing liver resection. Data were extracted by three independent researchers according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, Supplemental Digital Content 1, http://links.lww.com/JS9/A79. Several outcomes were evaluated, including postoperative peaks of transaminases and bilirubin, mortality, length of hospital stay, length of stay in the ICU, bleeding, and transfusion of blood products, among others. Bias risks were assessed using the Cochrane collaboration tool. Results: Seventeen articles were selected, with a total of 1052 patients. IPC did not change the surgical time of the liver resections while these patients bled less (Mean Difference: −49.97 ml; 95% CI: −86.32 to −13.6; I 2 : 64%), needed less blood products [relative risk (RR): 0.71; 95% CI: 0.53–0.96; I 2 =0%], and had a lower risk of postoperative ascites (RR: 0.40; 95% CI: 0.17–0.93; I 2 =0%). The other outcomes had no statistical differences or could not have their meta-analyses conducted due to high heterogeneity. Conclusions: IPC is applicable in clinical practice, and it has some beneficial effects. However, there is not enough evidence to encourage its routine use.
To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice.
OBJECTIVETo assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. SUMMARY BACKGROUND DATALiver surgeries are usually associated with intentional transient ischemia for hemostatic control. IPC is a surgical step that intends to reduce the effects of ischemia-reperfusion; however, there is no strong evidence about the real impact of the IPC, and it is necessary to effectively clarify what its effects are. METHODSRandomized clinical trials were selected, comparing IPC with no preconditioning in patients undergoing liver resection. Data were extracted by three independent researchers according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, Supplemental Digital Content 1, http://links.lww.com/JS9/A79 . Several outcomes were evaluated, including postoperative peaks of transaminases and bilirubin, mortality, length of hospital stay, length of stay in the ICU, bleeding, and transfusion of blood products, among others. Bias risks were assessed using the Cochrane collaboration tool. RESULTSSeventeen articles were selected, with a total of 1052 patients. IPC did not change the surgical time of the liver resections while these patients bled less (Mean Difference: -49.97 ml; 95% CI: -86.32 to -13.6; I2 : 64%), needed less blood products [relative risk (RR): 0.71; 95% CI: 0.53-0.96; I2 =0%], and had a lower risk of postoperative ascites (RR: 0.40; 95% CI: 0.17-0.93; I2 =0%). The other outcomes had no statistical differences or could not have their meta-analyses conducted due to high heterogeneity. CONCLUSIONSIPC is applicable in clinical practice, and it has some beneficial effects. However, there is not enough evidence to encourage its routine use.
To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. Liver surgeries are usually associated with intentional transient ischemia for hemostatic control. IPC is a surgical step that intends to reduce the effects of ischemia-reperfusion; however, there is no strong evidence about the real impact of the IPC, and it is necessary to effectively clarify what its effects are. Randomized clinical trials were selected, comparing IPC with no preconditioning in patients undergoing liver resection. Data were extracted by three independent researchers according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, Supplemental Digital Content 1, http://links.lww.com/JS9/A79 . Several outcomes were evaluated, including postoperative peaks of transaminases and bilirubin, mortality, length of hospital stay, length of stay in the ICU, bleeding, and transfusion of blood products, among others. Bias risks were assessed using the Cochrane collaboration tool. Seventeen articles were selected, with a total of 1052 patients. IPC did not change the surgical time of the liver resections while these patients bled less (Mean Difference: -49.97 ml; 95% CI: -86.32 to -13.6; I2 : 64%), needed less blood products [relative risk (RR): 0.71; 95% CI: 0.53-0.96; I2 =0%], and had a lower risk of postoperative ascites (RR: 0.40; 95% CI: 0.17-0.93; I2 =0%). The other outcomes had no statistical differences or could not have their meta-analyses conducted due to high heterogeneity. IPC is applicable in clinical practice, and it has some beneficial effects. However, there is not enough evidence to encourage its routine use.
Author de Oliveira, Glauber C
de Oliveira, Walmar K
Yoshida, Winston B
Sobreira, Marcone L
AuthorAffiliation Department of Surgery and Orthopedics, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil
AuthorAffiliation_xml – name: Department of Surgery and Orthopedics, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil
Author_xml – sequence: 1
  givenname: Glauber C
  orcidid: 0000-0003-3491-441
  surname: de Oliveira
  fullname: de Oliveira, Glauber C
  organization: Department of Surgery and Orthopedics, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil
– sequence: 2
  givenname: Walmar K
  surname: de Oliveira
  fullname: de Oliveira, Walmar K
– sequence: 3
  givenname: Winston B
  orcidid: 0000-0002-2921-3777
  surname: Yoshida
  fullname: Yoshida, Winston B
– sequence: 4
  givenname: Marcone L
  orcidid: 0000-0003-2271-5878
  surname: Sobreira
  fullname: Sobreira, Marcone L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36913265$$D View this record in MEDLINE/PubMed
BookMark eNpdUU1LAzEQDaKorf4DkRy9bE12s7uJF5HiJwUP6k0IMTtrI7tJTdKW_nsj1VKdywwzb958vAHatc4CQieUjCgR9fnDkxiRbctZsYMOac2KTNBS7G7FB2gQwgchjHDK99FBUQla5FV5iF7v-5nSMWDXYhP0FHqj8cyDdrYx0Thr7Ds2FndmAR57CKC_sxc4rEKEXsUE97AwsMRLE6e4h6gyZVW3CiYcob1WdQGOf_wQvdxcP4_vssnj7f34apJpRkTMNOSFYqDytF3VlKKBSrdtzmpoOG-gFJzlvGzLlHgTTHDKOCGgVLqACVVCMUSXa97Z_K2HRoONXnVy5k2v_Eo6ZeTfijVT-e4WkpKCi8SfGM5-GLz7nEOIsk_fgK5TFtw8yLzmVUlrWuUJytZQ7V0IHtrNHErktzIyKSP_K5PaTrd33DT9SlF8Acy0jXc
CitedBy_id crossref_primary_10_1097_JS9_0000000000001040
Cites_doi 10.1007/s11605-009-0878-7
10.1016/j.jhep.2009.06.028
10.1097/01.sla.0000246834.07130.5d
10.1097/00000658-200008000-00001
10.1016/j.amjsurg.2006.02.019
10.1016/j.surg.2014.09.005
10.1007/s00268-004-7431-3
10.3748/wjg.v10.i17.2580
10.1038/nm.2507
10.1136/bmj.n71
10.1016/j.clinre.2014.03.013
10.1093/bja/aeh195
10.1097/MD.0000000000008217
10.1016/j.ijsu.2018.05.001
10.1007/s00268-009-0117-0
10.1016/j.jamcollsurg.2005.10.021
10.1002/lt.20045
10.1590/S0102-76382010000400023
10.1001/archsurg.140.2.129
10.1097/01.sla.0000098620.27623.7d
10.1002/jso.21907
10.1097/SLA.0000000000003498
10.1002/bjs.9277
10.3748/wjg.v16.i15.1871
10.1136/bmj.j4008
ContentType Journal Article
Copyright Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023
Copyright_xml – notice: Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
– notice: Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1097/JS9.0000000000000243
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1743-9159
EndPage 1727
ExternalDocumentID 10_1097_JS9_0000000000000243
36913265
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
0SF
1B1
1P~
1~.
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AAAAV
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAIQE
AAKOC
AALRI
AAOAW
AAQFI
AASCR
AAWTL
ABBQC
ABMAC
ABMZM
ABVCZ
ACDAQ
ACGFS
ACILI
ACRLP
ACXJB
ADBBV
ADEZE
ADGGA
ADHPY
ADPDF
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGUBO
AGYEJ
AHQNM
AIEXJ
AIKHN
AINUH
AJNWD
AJOXV
AJRQY
AJUYK
AJZMW
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMJPA
AMKUR
AMNEI
ANZVX
AOHHW
AXJTR
BKOJK
BLXMC
BNPGV
CGR
CS3
CUY
CVF
DIWNM
EBS
ECM
EEVPB
EFJIC
EIF
EO8
EO9
EP2
EP3
F5P
FCALG
FDB
FEDTE
FIRID
FNPLU
G-Q
GBLVA
GNXGY
GQDEL
GROUPED_DOAJ
HVGLF
IKREB
IXB
J1W
KOM
MO0
N9A
NPM
O-L
O9-
OAUVE
OK-
OK1
OVD
OVDNE
OW-
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
TEORI
TSPGW
Z5R
~G-
1~5
AAXUO
AAYXX
ABVKL
ABXDB
ADMUD
ADVLN
AGHFR
AITUG
AMRAJ
CITATION
EJD
HX~
HZ~
IHE
M41
NCXOZ
ROL
7X8
AAHPQ
ABASU
ABDIG
AFDTB
5PM
ID FETCH-LOGICAL-c409t-ce23a4ea20816d59de6cff247ed88de5984285f547eb949814800eaa32649a5e3
ISSN 1743-9159
1743-9191
IngestDate Tue Sep 17 21:30:55 EDT 2024
Fri Oct 25 02:55:12 EDT 2024
Wed Sep 04 12:45:47 EDT 2024
Tue Aug 27 13:53:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c409t-ce23a4ea20816d59de6cff247ed88de5984285f547eb949814800eaa32649a5e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ORCID 0000-0003-3491-441
0000-0002-2921-3777
0000-0003-2271-5878
0000-0003-3491-441X
OpenAccessLink http://dx.doi.org/10.1097/JS9.0000000000000243
PMID 36913265
PQID 2786517162
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10389598
proquest_miscellaneous_2786517162
crossref_primary_10_1097_JS9_0000000000000243
pubmed_primary_36913265
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hagerstown, MD
PublicationTitle International journal of surgery (London, England)
PublicationTitleAlternate Int J Surg
PublicationYear 2023
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Clavien (R19-20240210) 2000; 232
Page (R4-20240210) 2021; 372
Li (R25-20240210) 2004; 10
Clavien (R20-20240210) 2003; 238
Shea (R5-20240210) 2017; 358
Guo (R13-20240210) 2017; 96
Rodríguez (R28-20240210) 2015; 157
Heizmann (R23-20240210) 2008; 13
Azoulay (R15-20240210) 2006; 202
Choukèr (R18-20240210) 2005; 140
Choukèr (R17-20240210) 2005; 29
Jung (R1-20240210) 2020; 271
Miranda (R6-20240210) 2004; 19
O’Neill (R12-20240210) 2013; 100
Rakić (R10-20240210) 2018; 54
Smyrniotis (R29-20240210) 2006; 192
Arkadopoulos (R14-20240210) 2009; 33
Eltzschig (R8-20240210) 2011; 17
Francischetti (R7-20240210) 2010; 25
Gurusamy (R11-20240210) 2009; 21
Choukèr (R16-20240210) 2004; 93
Domart (R21-20240210) 2009; 51
Heizmann (R24-20240210) 2010; 16
Neto (R2-20240210) 2005; 20
Nuzzo (R26-20240210) 2004; 10
Petrowsky (R27-20240210) 2006; 244
Montalvo-Jave (R9-20240210) 2009; 13
Castro e Silva (R3-20240210) 2002; 17
Hahn (R22-20240210) 2011; 104
Ye (R30-20240210) 2014; 38
References_xml – volume: 13
  start-page: 2074
  year: 2009
  ident: R9-20240210
  article-title: Role of ischemic preconditioning in liver surgery and hepatic transplantation
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-009-0878-7
  contributor:
    fullname: Montalvo-Jave
– volume: 51
  start-page: 881
  year: 2009
  ident: R21-20240210
  article-title: Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2009.06.028
  contributor:
    fullname: Domart
– volume: 244
  start-page: 921
  year: 2006
  ident: R27-20240210
  article-title: A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000246834.07130.5d
  contributor:
    fullname: Petrowsky
– volume: 232
  start-page: 155
  year: 2000
  ident: R19-20240210
  article-title: Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans
  publication-title: Ann Surg
  doi: 10.1097/00000658-200008000-00001
  contributor:
    fullname: Clavien
– volume: 192
  start-page: 669
  year: 2006
  ident: R29-20240210
  article-title: Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study
  publication-title: Am J Surg
  doi: 10.1016/j.amjsurg.2006.02.019
  contributor:
    fullname: Smyrniotis
– volume: 157
  start-page: 249
  year: 2015
  ident: R28-20240210
  article-title: Hepatic cytoprotective effect of ischemic and anesthetic preconditioning before liver resection when using intermittent vascular inflow occlusion: a randomized clinical trial
  publication-title: Surgery
  doi: 10.1016/j.surg.2014.09.005
  contributor:
    fullname: Rodríguez
– volume: 29
  start-page: 528
  year: 2005
  ident: R17-20240210
  article-title: Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection
  publication-title: World J Surg
  doi: 10.1007/s00268-004-7431-3
  contributor:
    fullname: Choukèr
– volume: 21
  start-page: CD007629
  year: 2009
  ident: R11-20240210
  article-title: Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: Gurusamy
– volume: 13
  start-page: 79
  year: 2008
  ident: R23-20240210
  article-title: Ischemic preconditioning improves postoperative outcome after liver resections: a randomized controlled study
  publication-title: Eur J Med Res
  contributor:
    fullname: Heizmann
– volume: 10
  start-page: 2580
  year: 2004
  ident: R25-20240210
  article-title: Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v10.i17.2580
  contributor:
    fullname: Li
– volume: 20
  start-page: 134
  year: 2005
  ident: R2-20240210
  article-title: Oxidative alterations, total antioxidant status and nitric oxide study in rats submitted to ischemia and reperfusion of hind limbs
  publication-title: Acta Cir Bras
  contributor:
    fullname: Neto
– volume: 17
  start-page: 1391
  year: 2011
  ident: R8-20240210
  article-title: Ischemia and reperfusion – from mechanism to translation
  publication-title: Nat Med
  doi: 10.1038/nm.2507
  contributor:
    fullname: Eltzschig
– volume: 372
  start-page: n71
  year: 2021
  ident: R4-20240210
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: BMJ
  doi: 10.1136/bmj.n71
  contributor:
    fullname: Page
– volume: 19
  start-page: 3
  year: 2004
  ident: R6-20240210
  article-title: The experimental basis of hepatic ischemia–reperfusion injury: review
  publication-title: Acta Cir Bras
  contributor:
    fullname: Miranda
– volume: 38
  start-page: 467
  year: 2014
  ident: R30-20240210
  article-title: Ischemic preconditioning provides no additive clinical value in liver resection of cirrhotic and non-cirrhotic patients underportal triad clamping: a prospective randomized controlled trial
  publication-title: Clin Res Hepatol Gastroenterol
  doi: 10.1016/j.clinre.2014.03.013
  contributor:
    fullname: Ye
– volume: 93
  start-page: 204
  year: 2004
  ident: R16-20240210
  article-title: Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial
  publication-title: Br J Anaesth
  doi: 10.1093/bja/aeh195
  contributor:
    fullname: Choukèr
– volume: 96
  start-page: e8217
  year: 2017
  ident: R13-20240210
  article-title: Meta-analysis of ischemic preconditioning (IP) on postoperative outcomes after liver resections
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000008217
  contributor:
    fullname: Guo
– volume: 17
  start-page: 96
  year: 2002
  ident: R3-20240210
  article-title: Basics aspects of the ischemia-reperfusion injury and of the ischemic preconditioning
  publication-title: Acta Cir Bras
  contributor:
    fullname: Castro e Silva
– volume: 54
  start-page: 248
  issue: Pt A
  year: 2018
  ident: R10-20240210
  article-title: Comparison of hepatoprotective effect from ischemia–reperfusion injury of remote ischemic preconditioning of the liver vs local ischemic preconditioning of the liver during human liver resections
  publication-title: Int J Surg
  doi: 10.1016/j.ijsu.2018.05.001
  contributor:
    fullname: Rakić
– volume: 33
  start-page: 1909
  year: 2009
  ident: R14-20240210
  article-title: Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial
  publication-title: World J Surg
  doi: 10.1007/s00268-009-0117-0
  contributor:
    fullname: Arkadopoulos
– volume: 202
  start-page: 203
  year: 2006
  ident: R15-20240210
  article-title: Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study
  publication-title: J Am Coll Surg
  doi: 10.1016/j.jamcollsurg.2005.10.021
  contributor:
    fullname: Azoulay
– volume: 10
  start-page: S53
  issue: 2 suppl 1
  year: 2004
  ident: R26-20240210
  article-title: Pedicle clamping with ischemic preconditioning in liver resection
  publication-title: Liver Transpl
  doi: 10.1002/lt.20045
  contributor:
    fullname: Nuzzo
– volume: 25
  start-page: 575
  year: 2010
  ident: R7-20240210
  article-title: Leukocytes and the inflammatory response in ischemia-reperfusion injury
  publication-title: Braz J Cardiovasc Surg
  doi: 10.1590/S0102-76382010000400023
  contributor:
    fullname: Francischetti
– volume: 140
  start-page: 129
  year: 2005
  ident: R18-20240210
  article-title: Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils
  publication-title: Arch Surg
  doi: 10.1001/archsurg.140.2.129
  contributor:
    fullname: Choukèr
– volume: 238
  start-page: 843
  year: 2003
  ident: R20-20240210
  article-title: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000098620.27623.7d
  contributor:
    fullname: Clavien
– volume: 104
  start-page: 647
  year: 2011
  ident: R22-20240210
  article-title: The effect of ischemic preconditioning on redox status during liver resections – randomized controlled trial
  publication-title: J Surg Oncol
  doi: 10.1002/jso.21907
  contributor:
    fullname: Hahn
– volume: 271
  start-page: 646
  year: 2020
  ident: R1-20240210
  article-title: Effect of remote ischemic preconditioning conducted in living liver donors on postoperative liver function in donors and recipients following liver transplantation: a randomized clinical trial
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000003498
  contributor:
    fullname: Jung
– volume: 100
  start-page: 1689
  year: 2013
  ident: R12-20240210
  article-title: Meta-analysis of ischaemic preconditioning for liver resections
  publication-title: Br J Surg
  doi: 10.1002/bjs.9277
  contributor:
    fullname: O’Neill
– volume: 16
  start-page: 1871
  year: 2010
  ident: R24-20240210
  article-title: Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v16.i15.1871
  contributor:
    fullname: Heizmann
– volume: 358
  start-page: j4008
  year: 2017
  ident: R5-20240210
  article-title: AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
  publication-title: BMJ
  doi: 10.1136/bmj.j4008
  contributor:
    fullname: Shea
SSID ssj0040818
Score 2.3685284
SecondaryResourceType review_article
Snippet To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. Liver surgeries are...
Objective: To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. Summary...
OBJECTIVETo assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice. SUMMARY...
To assess the beneficial effects of ischemic preconditioning (IPC) in liver resection and evaluate its applicability in clinical practice.
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1720
SubjectTerms Hemostasis
Hepatectomy - adverse effects
Humans
Ischemic Preconditioning
Length of Stay
Liver - surgery
Reviews
Title Impacts of ischemic preconditioning in liver resection: systematic review with meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/36913265
https://search.proquest.com/docview/2786517162
https://pubmed.ncbi.nlm.nih.gov/PMC10389598
Volume 109
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWcuGCQLy2PGQkblGWNLGTmBtUQCkUDm1FD0iRHU_USNts1c0KiR_K72Ecx9kkBETZQ7SyE8vxfBnP2DOfCXkhkkKxIpD-HqBvgjME81OVS1-yIlKAc16hzI7u0ef44JQdnvGz2exnL2ppU6tF_mMyr-R_pIplKFeTJXsNyXaNYgH-R_niFSWM13-S8YcmxdGyxqKX2sS5XzYuri7dQmtZeUsTe-GZPKPchXKMCZy_2wXZC6hxAFuekr7dOlw47NFNrG1a9eTJIL1VBg3eF9ONsjnWyHu_lBuFfdpf_OGGr3J5Ia-8j4utVlqfl9rWlVVDBvKmqzxeoWPfPnmEX-4KLedPi_6CRhhtA69aHZw0AQEtUThMlDnFHYgeQvtqGK2yoDelGyNtcrqwNMSHx8LSWLpfaJmjhuzco1mzi2V0u_jYSjZu5Qa5GaICjJ2rby0EZmgEbaKufSmX0imSl1N9GZpMv_lB43Denn10cofcbh0b-tqi9C6ZQXWPfGsRSlcFdQilI4TSsqINQmmH0Fd0i09q8UkNPukAn_fJ6bu3J_sHfnueh5-zQNR-DmEkGcjQHPaiudAQ50URsgR0mmrgIkVfmBccC5RgIkVPPQhASvQwmJAcogdkp0IEPSJUxzoOmQIoYs0gYornKSQxVxHL0wRgTnw3ZNmlpW3J_iaoOXnuxjVD_Wo2zWQFq806C5M05oZTKpyTh3acuxajWOxh5_icpAMJdDcY7vZhTVWeNxzu5lwCgW-8e82OPia3tt_ME7JTX23gKZrFtXrWYOwXdPS1mA
link.rule.ids 230,315,783,787,867,888,27936,27937
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impacts+of+ischemic+preconditioning+in+liver+resection%3A+systematic+review+with+meta-analysis&rft.jtitle=International+journal+of+surgery+%28London%2C+England%29&rft.au=de+Oliveira%2C+Glauber+C.&rft.au=de+Oliveira%2C+Walmar+K.&rft.au=Yoshida%2C+Winston+B.&rft.au=Sobreira%2C+Marcone+L.&rft.date=2023-06-01&rft.issn=1743-9159&rft.eissn=1743-9159&rft.volume=109&rft.issue=6&rft.spage=1720&rft.epage=1727&rft_id=info:doi/10.1097%2FJS9.0000000000000243&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_JS9_0000000000000243
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-9159&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-9159&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-9159&client=summon